Reaction
Paradoxical Psoriasis reporting signals
As of the last recalculation, Paradoxical Psoriasis appears in 416 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB-AATY (PRR 324.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab-Aaty | 177 | 324.9 | 326.2 |
| Adalimumab-Fkjp | 169 | 306.8 | 307.9 |
| Adalimumab-Adaz | 172 | 277.3 | 278.2 |
| Infliximab | 132 | 43.8 | 43.9 |
| Ixekizumab | 12 | 16.7 | 16.7 |
| Bimekizumab | 6 | 14.3 | 14.3 |